Aptose Biosciences is a biotechnology company that specializes in developing tailored treatments for oncology-related medical needs. The company has several clinical programs in different stages of development, including APTO-253 and HM43239 that treat various types of relapsed or refractory blood cancers. It also works on a few other different therapies in clinical trials with different partners.